Evidence map›Paper›PMID 34468167›Full record

ArticlemSphere2021

MCR-5-Producing Colistin-Resistant Cupriavidus gilardii Strain from Well Water in Batna, Algeria.

Zineb Cherak, Lotfi Loucif, Mariem Ben Khedher, Abdelhamid Moussi, Amel Benbouza, Sophie Alexandra Baron, Jean-Marc Rolain

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Clinical Management of SevereInfectious disease reports · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. A Systematic Review and Comprehensive Analysis ofAntibiotics (Basel, Switzerland) · 2024
    Review
  11. Genomic Sequencing of ClinicalInfection and drug resistance · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Zineb CherakLaboratoire de Génétique, Biotechnologie et Valorisation des Bio-ressources (GBVB), Faculté des Sciences Exactes et des Sciences de la Nature et de la Vie, Université Mohamed Khider, Biskra, Algeria.ORCID 0000-0002-5921-7955
Lotfi LoucifLaboratoire de Biotechnologie des Molécules Bioactives et de la Physiopathologie Cellulaire (LBMBPC), Faculté des Sciences de la Nature et de la Vie, Université de Batna 2, Batna, Algeria.ORCID 0000-0001-5246-9132
Mariem Ben KhedherAix Marseille Univ., IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Abdelhamid MoussiLaboratoire de Génétique, Biotechnologie et Valorisation des Bio-ressources (GBVB), Faculté des Sciences Exactes et des Sciences de la Nature et de la Vie, Université Mohamed Khider, Biskra, Algeria.
Amel BenbouzaFaculté de Médecine, Université de Batna 2, Batna, Algeria.
Sophie Alexandra BaronAix Marseille Univ., IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Jean-Marc RolainAix Marseille Univ., IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Aix-Marseille Université · FRUniversity of Batna 1 · DZUniversity of Biskra · DZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents the first description of the

Indexed as

Water WellsAlgeriaAnti-Bacterial AgentsColistinCupriavidusDrug Resistance, BacterialWater MicrobiologyAnti-Bacterial AgentsColistinAlgeriacolistin resistanceCupriavidus gilardiigroundwatermcr-5

Identifiers

PMID34468167
PMCPMC8550137
OpenAlexW3197843242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.